DISCOUNT OPTIONSSCHEIN - NOVO NORDISK ADR B Share Price

Certificat

DE000ME21ZX7

Market Closed - Börse Stuttgart 20:20:14 05/07/2024 BST
0.036 EUR +20.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - NOVO NORDISK ADR B
Current month-7.69%
1 month-10.00%
Date Price Change
05/07/24 0.036 +20.00%
04/07/24 0.03 -14.29%
03/07/24 0.035 -5.41%
02/07/24 0.037 -7.50%
01/07/24 0.04 +2.56%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 08:20 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME21ZX
ISINDE000ME21ZX7
Date issued 13/10/2023
Strike 75 $
Maturity 20/09/2024 (77 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.212
Lowest since issue 0.022

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974 DKK
Average target price
952.2 DKK
Spread / Average Target
-2.24%
Consensus